References
- Cowdry R. W., Goodwin F. K. Amine neurotransmitter studies and psychiatric illness: toward more meaningful diagnostic concepts. Critical Issues in Psychiatric Diagnosis, R. L. Spitzer, D. F. Klein. Raven Press, New York 1978; 281–304
- Murphy D. L., Campbell I. C., Costa J. L. The brain serotonergic system in the affective disorders. Prog Neuropsychopharmacol 1978; 2: 1–31
- Traskman L., Asberg M., Bertilsson L., Sjostrand L. Monoamine metabolities in Csf and suicidal behaviour. Arch. Gen. Psych. 1981; 38: 631–636
- Ross S. B., Ogren S. O., Renyi A. L. (Z)-dimethyl-amino-a-(4 bromophenyl)-1-(3-pyridyl) propene (H 102/09) a new selective inhibitor of the neuronal 5-hydroxytyptamine uptake. Acta Pharmacol Toxicol 1976; 39: 152–166
- Maas J. W. Clinical implications of pharmacological differences among antidepressants. sychopharmacology: a Generation of Progress, M. A. Lipton, A. Mascio, K. F. Killan. PRaven Press, New York 1978, 1978
- Waldmeir P. C., Greengrass P. M., Baumann P., Maitre L. Effects of Clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover. Post Graduate Medical Journal 1976; 52(Suppl. 3)33–39